Nanomedicine strategies for overcoming multidrug resistance in breast cancer: recent advances and future perspectives

Mohit Kumar, Tejaswi, Rohit Bangwal, Manish Yadav, Rahul Singh · 2026

Read Nanomedicine strategies for overcoming multidrug resistance in breast cancer: recent advances and future perspectives by Mohit Kumar, Tejaswi, Rohit Bangwal, Manish Yadav, Rahul Singh (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13518755.txt.

Description

Mohit Kumar and four co-authors review how tiny-scale medicine can break drug resistance in breast cancer. Resistance drives treatment failure, return of the cancer, and poor outcomes. Its roots include pumps that push drugs out of cells, evasion of cell death, a shift in cell type, and stubborn cancer stem cells. Tiny carriers can raise drug delivery, boost drug buildup inside cells, and enable targeted or combined therapy.

The review walks through liposomes, solid lipid particles, polymer particles, inorganic carriers, nanoemulsions, and targeted systems. It stresses plans that pair standard drugs with natural compounds, gene modulators, or sensitizers, which worked better in lab and animal models. Limits and future prospects get frank treatment as well.

Catalog record

CREATORMohit Kumar, Tejaswi, Rohit Bangwal, Manish Yadav, Rahul Singh
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13518755

Browse the full library · About the Tower of Babel